DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Mark Cuban Cost Plus Drug Company sells generics at manufacturer cost + 15% + $3 fill fee. GLP-1s are NOT carried because no FDA-approved generics exist.
Mail-order only. Cost Plus does not sell brand-name GLP-1s and does not compound. Future generics (post-2032 for semaglutide) would be a natural fit.
Not applicable to GLP-1s currently.
No GLP-1 inventory.
Cost Plus generally does not accept insurance. Cash-pay model.
NOT a current GLP-1 route. Bookmark for late 2032 when semaglutide generics may become available in the US.
Useful for non-GLP-1 generics in your formulary stack. Watch for 2032+ generic semaglutide listings; Cost Plus will likely be among the first cash-pay channels.
Editorial summary. Pricing and inventory shift frequently. Confirm with the pharmacy directly before relying on any single source.